These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 14962990

  • 1. Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
    Wang FS, Wang CJ, Chen YJ, Huang YT, Huang HC, Chang PR, Sun YC, Yang KD.
    Endocrinology; 2004 May; 145(5):2148-56. PubMed ID: 14962990
    [Abstract] [Full Text] [Related]

  • 2. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide regulates receptor activator of nuclear factor-kappaB ligand and osteoprotegerin expression in bone marrow stromal cells.
    Fan X, Roy E, Zhu L, Murphy TC, Ackert-Bicknell C, Hart CM, Rosen C, Nanes MS, Rubin J.
    Endocrinology; 2004 Feb; 145(2):751-9. PubMed ID: 14563699
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
    Yamada N, Tsujimura T, Ueda H, Hayashi S, Ohyama H, Okamura H, Terada N.
    Cytokine; 2005 Aug 21; 31(4):288-97. PubMed ID: 15996478
    [Abstract] [Full Text] [Related]

  • 6. Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in osteoblasts.
    Takami M, Takahashi N, Udagawa N, Miyaura C, Suda K, Woo JT, Martin TJ, Nagai K, Suda T.
    Endocrinology; 2000 Dec 21; 141(12):4711-9. PubMed ID: 11108286
    [Abstract] [Full Text] [Related]

  • 7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 21; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vector-averaged gravity regulates gene expression of receptor activator of NF-kappaB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway.
    Kanematsu M, Yoshimura K, Takaoki M, Sato A.
    Bone; 2002 Apr 21; 30(4):553-8. PubMed ID: 11934645
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
    Endocrinology; 2000 Sep 21; 141(9):3478-84. PubMed ID: 10965921
    [Abstract] [Full Text] [Related]

  • 12. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
    Quinn JM, Horwood NJ, Elliott J, Gillespie MT, Martin TJ.
    J Bone Miner Res; 2000 Aug 21; 15(8):1459-66. PubMed ID: 10934644
    [Abstract] [Full Text] [Related]

  • 13. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.
    Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL.
    Endocrinology; 2000 Dec 21; 141(12):4768-76. PubMed ID: 11108292
    [Abstract] [Full Text] [Related]

  • 14. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
    Koh JM, Lee YS, Byun CH, Chang EJ, Kim H, Kim YH, Kim HH, Kim GS.
    J Endocrinol; 2005 Jun 21; 185(3):401-13. PubMed ID: 15930166
    [Abstract] [Full Text] [Related]

  • 15. Deflazacort increases osteoclast formation in mouse bone marrow culture and the ratio of RANKL/OPG mRNA expression in marrow stromal cells.
    Chung H, Kang YS, Hwang CS, Moon IK, Yim CH, Choi KH, Han KO, Jang HC, Yoon HK, Han IK.
    J Korean Med Sci; 2001 Dec 21; 16(6):769-73. PubMed ID: 11748360
    [Abstract] [Full Text] [Related]

  • 16. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
    Shin HH, Kim SJ, Kang SY, Lee DS, Choi HS.
    Bone; 2006 Oct 21; 39(4):716-23. PubMed ID: 16750437
    [Abstract] [Full Text] [Related]

  • 17. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.
    Aubin JE, Bonnelye E.
    Osteoporos Int; 2000 Oct 21; 11(11):905-13. PubMed ID: 11193242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK, Lorenzo JA.
    Endocrinology; 1999 Aug 21; 140(8):3552-61. PubMed ID: 10433211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.